David Thiele
Family Medicine · Brandon, FLNPI 1427168905
Payments from drug & device makers
Across 149 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$753
- Lilly USA, LLC$596
- GSK$375
- Boehringer Ingelheim$302
- Johnson & Johnson$223
- Novartis$139
- plus $391 from 8 others
What the payments were for
- Food & beverage$2,780100%
- Education$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 41 | $753 |
| Lilly USA, LLC | 31 | $596 |
| GSK | 23 | $375 |
| Boehringer Ingelheim | 14 | $302 |
| Johnson & Johnson | 14 | $223 |
| Novartis | 7 | $139 |
| Pfizer | 6 | $127 |
| Avanir Pharmaceuticals, Inc. | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Merck | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Astellas Pharma US Inc | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Philips North America LLC | 1 | $16 |
How this compares
$2,780 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 101 | $104,617 |
| JardianceEmpagliflozin | 27 | $48,382 |
| EliquisApixaban | 41 | $42,883 |
| OzempicSemaglutide | 28 | $41,518 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $26,569 |
| TrulicityDulaglutide | 17 | $23,373 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $21,641 |
| MyrbetriqMirabegron | 20 | $11,263 |
| BrilintaTicagrelor | 16 | $10,333 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 27 | $4,728 |
| Duloxetine Hcl | 115 | $4,714 |
| Diltiazem 12hr ErDiltiazem Hcl | 14 | $4,392 |
| Gabapentin | 97 | $3,671 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $3,535 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 171 | $3,231 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $753 | $141,519145 claims |
| Boehringer IngelheimJardiance | $302 | $48,38227 claims |
| PfizerEliquis, Paxlovid | $127 | $45,66556 claims |
| Lilly USA, LLCTrulicity | $596 | $23,37317 claims |
| GSKTrelegy Ellipta | $375 | $21,64124 claims |
| Astellas Pharma US IncMyrbetriq | $18 | $11,26320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Brandon
- German AlvarezBrandon$4.9M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.